Related references
Note: Only part of the references are listed.The Promise and Perils of Stem Cell Therapeutics
George Q. Daley
CELL STEM CELL (2012)
Catastrophic Demyelinating Encephalomyelitis After Intrathecal and Intravenous Stem Cell Transplantation in a Patient With Multiple Sclerosis
Yazan J. Alderazi et al.
JOURNAL OF CHILD NEUROLOGY (2012)
China's stem-cell rules go unheeded
David Cyranoski
NATURE (2012)
Tourism ban won't help Indian tigers
Ralf C. Buckley et al.
NATURE (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Improving oversight of innovative medical interventions in Texas, USA
Aaron D. Levine
REGENERATIVE MEDICINE (2012)
Texas Medical Board Approves Rules for Controversial Treatment
Jocelyn Kaiser
SCIENCE (2012)
Time-dependent fate of transplanted neural precursor cells in experimental autoimmune encephalomyelitis mice
Angeliki Giannakopoulou et al.
EXPERIMENTAL NEUROLOGY (2011)
Are You Tilting at Windmills or Undertaking a Valid Clinical Trial?
John D. Steeves et al.
YONSEI MEDICAL JOURNAL (2011)
Defining the risks of mesenchymal stromal cell therapy
Darwin J. Prockop et al.
CYTOTHERAPY (2010)
Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy
Duangpen Thirabanjasak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
FDA Regulation of Stem Cell-Based Products
Donald W. Fink
SCIENCE (2009)
Share Paper
